Kathleen Hoffman, PhD

Kathleen Hoffman, PhD

About Kathleen Hoffman, PhD

Kathleen is a communications professional, social scientist and writer who develops evidence-based communications focused on the human side of healthcare. Her research background includes experimental studies in communication, persuasion, health communication and the media and qualitative research focused on content analysis, frame analysis and ethnography. As a professional writer and communicator of nearly two decades, Kathleen is a leader in the patient empowerment movement. Kathleen earned her PhD in Communications from the University of Alabama, preceded by a master’s degree in Television and Film from Syracuse University and a master’s degree in Public Health at UNC-Chapel Hill. She was also a two-time fellow of Healthcare Communication at Harvard University’s School of Public Health. Kathleen lives near Boston with her husband and son.
Senior Health Researcher and Writer

Getting the Most from Online Surveys

Getting the Most from Online Surveys By Kathleen Hoffman, PhD, MSPH Do you wonder about online surveys? Are they reliable? Is there bias? A recent article by the Pew Research Center For Weighting Online Opt-In Samples, What Matters Most? 1provides guidance to allay those concerns. Pew experimented with different procedures for [...]

Do You Really Know How Patients Talk About Their Condition?

Do You Really Know How Patients Talk About Their Condition? By Kathleen Hoffman, PhD MSPH There are classic examples of advertising messages that ended up offending the target customer, but the Utah Department of Transportation provided the most recent. The Utah DOT’s lighthearted attempt to adopt a specific culture’s way of [...]

Clinical Trials and PROs: What Patients with Rare Diseases Say

Clinical Trials and PROs: What Patients with Rare Diseases Say By Kathleen Hoffman, PhD MSPH Challenges to developing clinical trials for rare diseases begin with their rarity – each condition affects fewer than 200,000 Americans. Approximately seventy-five percent of those affected by rare diseases are children. It is estimated that 80 [...]

What Members Tell Each Other About Clinical Trials

What Members Tell Each Other About Clinical Trials By Kathleen Hoffman, PhD MSPH "Failing to enroll a sufficient number of subjects in a trial is a long-standing problem"1 but understanding the factors impeding enrollment can be difficult. Public posts on social media are an effective resource for understanding how patients feel [...]

What’s the FDA up to on Patient Focused Drug Development (PFDD) these days?

What’s the FDA up to on Patient-Focused Drug Development (PFDD) these days? By Kathleen Hoffman, PhD MSPH Part of the FDA’s mandate in implementing the “21st Century Cures Act” is ensuring the incorporation of patient experience data into drug development. They’ve hit the deadline for another Patient Focused Drug Development (PFDD) [...]

HPV is Not in Scarlet Letters: Cervical Cancer Patients Being Stigmatized

HPV is Not in Scarlet Letters: Cervical Cancer Patients Being Stigmatized By Kathleen Hoffman, PhD, MSPH Imagine being given a diagnosis of cervical cancer. That’s bad enough. Now, imagine that it comes with the assumption you got it by sleeping around. In 1983 and 1984, Dr. Harold zur Hausen isolated Human [...]

Getting Told You’re Making It All Up: Lupus

Getting Told You're Making It All Up By Kathleen Hoffman, PhD, MSPH Imagine going to see a doctor when you’re exhausted and enduring multiple kinds of pain, and they recommend a “psych” evaluation. When they “can’t find anything,” the medical professional you looked to for help decides you must be making [...]

Prostate Cancer: A Couple’s Disease

Prostate Cancer: "A Couple's Disease" By Kathleen Hoffman, PhD, MSPH Prostate cancer impacts not just the physical health of the individual but also their emotional and social health. A study of patients and their partners compared satisfaction with treatment, worry about cancer, and the consequences of treatment on their relationship. Twenty-five [...]